News publications and other organizations are encouraged to reuse Direct Relief-published content for free under a Creative Commons License (Attribution-Non-Commercial-No Derivatives 4.0 International), given the republisher complies with the requirements identified below.

When republishing:

  • Include a byline with the reporter’s name and Direct Relief in the following format: "Author Name, Direct Relief." If attribution in that format is not possible, include the following language at the top of the story: "This story was originally published by Direct Relief."
  • If publishing online, please link to the original URL of the story.
  • Maintain any tagline at the bottom of the story.
  • With Direct Relief's permission, news publications can make changes such as localizing the content for a particular area, using a different headline, or shortening story text. To confirm edits are acceptable, please check with Direct Relief by clicking this link.
  • If new content is added to the original story — for example, a comment from a local official — a note with language to the effect of the following must be included: "Additional reporting by [reporter and organization]."
  • If republished stories are shared on social media, Direct Relief appreciates being tagged in the posts:
    • Twitter (@DirectRelief)
    • Facebook (@DirectRelief)
    • Instagram (@DirectRelief)

Republishing Images:

Unless stated otherwise, images shot by Direct Relief may be republished for non-commercial purposes with proper attribution, given the republisher complies with the requirements identified below.

  • Maintain correct caption information.
  • Credit the photographer and Direct Relief in the caption. For example: "First and Last Name / Direct Relief."
  • Do not digitally alter images.

Direct Relief often contracts with freelance photographers who usually, but not always, allow their work to be published by Direct Relief’s media partners. Contact Direct Relief for permission to use images in which Direct Relief is not credited in the caption by clicking here.

Other Requirements:

  • Do not state or imply that donations to any third-party organization support Direct Relief's work.
  • Republishers may not sell Direct Relief's content.
  • Direct Relief's work is prohibited from populating web pages designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
  • Advance permission is required to translate Direct Relief's stories into a language different from the original language of publication. To inquire, contact us here.
  • If Direct Relief requests a change to or removal of republished Direct Relief content from a site or on-air, the republisher must comply.

For any additional questions about republishing Direct Relief content, please email the team here.

Partnership Launches to Help People Living with Rare Disease


Rare Disease

Coinciding with Rare Disease Day, Direct Relief is excited to announce a new collaboration with biopharmaceutical company, Shire HGT, to help patients living with lysosomal storage disorders (LSDs) – a class of rare diseases.

In the U.S., a rare disease – also known as an orphan disease – is defined as a disease or condition that affects less than 200,000 people.  While the individual conditions are uncommon in themselves, worldwide there are about 350 million people living with one of the estimated 7,000 known rare diseases.

Many rare diseases do not have available treatment, but Shire HGT has developed enzyme replacement therapies (ERT) for Fabry disease, Gaucher disease, and Hunter syndrome – all three are types of lysosomal storage disorders.

To help those living with LSD’s access this treatment and specialty care, Shire HGT and Direct Relief are working to help provide free, high-quality, individualized treatment to patients around the world who would otherwise not be able to receive care.

Direct Relief will serve as a liaison between Shire HGT, the patient and their family, the treating physician, and the medical facility where care and treatment will take place to ensure a regular donation of ERT is delivered and that all medical-related components are in place for treatment to be effectively provided.

This initiative is just beginning, but we look forward to collaborating on behalf of rare disease patients. We will share more about the partnership in the coming weeks.

Giving is Good Medicine

You don't have to donate. That's why it's so extraordinary if you do.